Industry-defined opportunities for advancing big data capabilities in biopharmaceutical manufacturing

Roger Hart, Sandeep Kedia, Rachel Lanspa, Sarah Lichtner, Kelvin H. Lee

Open source

DOI
10.3389/fbioe.2026.1886721
Published
2026-09-04
Container
Frontiers in Bioengineering and Biotechnology
Publisher
Frontiers Media SA
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fbioe.2026.1886721,
  title = {Industry-defined opportunities for advancing big data capabilities in biopharmaceutical manufacturing},
  author = {Roger Hart and Sandeep Kedia and Rachel Lanspa and Sarah Lichtner and Kelvin H. Lee},
  year = {2026},
  journal = {Frontiers in Bioengineering and Biotechnology},
  doi = {10.3389/fbioe.2026.1886721},
  url = {https://doi.org/10.3389/fbioe.2026.1886721}
}

RIS

TY  - JOUR
TI  - Industry-defined opportunities for advancing big data capabilities in biopharmaceutical manufacturing
AU  - Roger Hart
AU  - Sandeep Kedia
AU  - Rachel Lanspa
AU  - Sarah Lichtner
AU  - Kelvin H. Lee
PY  - 2026
JO  - Frontiers in Bioengineering and Biotechnology
DO  - 10.3389/fbioe.2026.1886721
UR  - https://doi.org/10.3389/fbioe.2026.1886721
ER  - 

APA

Hart, R., Kedia, S., Lanspa, R., Lichtner, S., & Lee, K. H. (2026). Industry-defined opportunities for advancing big data capabilities in biopharmaceutical manufacturing. Frontiers in Bioengineering and Biotechnology. https://doi.org/10.3389/fbioe.2026.1886721

Source records